CD9 and central nervous system cancer: In glioma, a study exploring EVs released by proneural, and mesenchymal glioma stem cells (GSCs) identified that proneural GSC-derived EVs lacked canonical EV-based tetraspanin markers such as CD9, CD63, and CD81, while they were abundant in mesenchymal GSC-derived EVs.